(Q21144332)

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer (English)

0 references

Retracted: An Integrated Approach to the Prediction of Chemotherapeutic Response in Patients with Breast Cancer (English)

0 references

0 references

0 references

0 references

Sayan Mukherjee

8

Sayan

Mukherjee

1 reference

16 August 2022

Kelly H Salter

1

Kelly H

Salter

1 reference

16 August 2022

Chaitanya R Acharya

2

Chaitanya R

Acharya

1 reference

16 August 2022

Kelli S Walters

3

Kelli S

Walters

1 reference

16 August 2022

Richard Redman

4

Richard

Redman

1 reference

16 August 2022

Ariel Anguiano

5

Ariel

Anguiano

1 reference

16 August 2022

Katherine S Garman

6

Katherine S

Garman

1 reference

16 August 2022

Carey K Anders

7

Carey K

Anders

1 reference

16 August 2022

Holly K Dressman

9

Holly K

Dressman

1 reference

16 August 2022

William T Barry

10

William T

Barry

1 reference

16 August 2022

Kelly P Marcom

11

Kelly P

Marcom

1 reference

16 August 2022

John Olson

12

John

Olson

1 reference

16 August 2022

Joseph R Nevins

13

Joseph R

Nevins

1 reference

16 August 2022

Anil Potti

14

Anil

Creative Commons Attribution 4.0 International

Potti

1 reference

16 August 2022

language of work or name

English

0 references

publication date

2008

0 references

published in

PLOS One

0 references

volume

3

0 references

page(s)

e1908

0 references

issue

4

0 references

copyright license

start time

2 April 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

is retracted by

Retraction: An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer

0 references

cites work

A microRNA expression signature of human solid tumors defines cancer gene targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

A microRNA component of the p53 tumour suppressor network

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

Transcriptional activation of miR-34a contributes to p53-mediated apoptosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

Mining gene expression profiles: expression signatures as cancer phenotypes

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

The 17q12-q21 amplicon: Her2 and topoisomerase-IIalpha and their importance to the biology of solid tumours.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

Genomic signatures to guide the use of chemotherapeutics.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

Chemosensitivity prediction by transcriptional profiling

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

p53-mediated activation of miRNA34 candidate tumor-suppressor genes.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

Pharmacogenomic predictor discovery in phase II clinical trials for breast cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.

30 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0001908

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0001908

HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0001908

Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270912

Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results

29 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18382681

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Predictive cancer genomics--what do we need?

1 reference

COCI

https://opencitations.net/index/api/v1/references/10.1371/JOURNAL.PONE.0001908